Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in Central Africa has been experiencing significant growth in recent years.
Customer preferences: Customers in Central Africa have been increasingly seeking out alternative and complementary medicines, leading to a rise in demand for Other Pharmaceuticals. Additionally, the growing prevalence of chronic diseases, such as diabetes and hypertension, has also contributed to the expansion of the market.
Trends in the market: One of the key trends in the Other Pharmaceuticals market in Central Africa is the increasing popularity of traditional medicines. Many consumers in the region place a high value on traditional healing practices and natural remedies, which has led to a rise in demand for herbal and plant-based medicines. Another trend in the market is the growth of e-commerce, which has made it easier for consumers to access a wider range of products and has helped to increase competition among suppliers.
Local special circumstances: The Other Pharmaceuticals market in Central Africa is heavily influenced by local cultural and economic factors. In many countries in the region, there is a strong tradition of using traditional medicines, which has helped to drive demand for these products. Additionally, many consumers in the region face economic challenges and have limited access to healthcare, which has led them to seek out alternative and more affordable treatments.
Underlying macroeconomic factors: Several macroeconomic factors have contributed to the growth of the Other Pharmaceuticals market in Central Africa. These include rising levels of urbanization, which has led to an increase in demand for healthcare products and services, as well as the growing prevalence of chronic diseases. Additionally, improvements in transportation infrastructure and the growth of e-commerce have helped to make it easier for suppliers to reach customers in more remote areas. Finally, many countries in the region have implemented policies aimed at promoting the use of traditional medicines, which has helped to boost demand for these products.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
